임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
19건 표시
- 1/2상모집 예정· Myeloma MultipleEtenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma
협력: 애브비, 사노피
- 1/2상모집 예정· Acute Lymphoblastic LeukemiaHEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
협력: 애브비, 아스트라제네카
- 1/2상모집 예정· JAK1 GOFUpadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations
협력: 애브비
- 4상모집 예정· UC - Ulcerative ColitisUpadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis
협력: 애브비
- 단계 미표기모집 예정· Folate Receptor-Alpha Positive Platinum-Resistant High-Grade Serous Epithelial Ovarian CancerA Study to Evaluate Adverse Events and Change in Disease Activity of Mirvetuximab Soravtansine-gynx in Adults With Folate Receptor-Alpha Positive, Platinum-Resistant Ovarian Cancer in a Real-World Setting
리드: 애브비
- 1상모집 예정· Healthy VolunteerStudy to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult Participants
리드: 애브비
- 1상모집 예정· Healthy VolunteerA Study to Evaluate How Multiple Doses of Itraconazole Interacts With Nacresertib in Healthy Adult Participants
리드: 애브비
- 단계 미표기모집 예정· Diabetic Macular EdemaA Study to Assess the Use of Artificial Intellignce to Predict Eye Treatment Changes in Adult Participants With Diabetic Macular Edema
리드: 애브비
- 2상모집 예정· Aggressive Diffuse Large B-cell LymphomaCombining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
협력: 애브비
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.